2021-03-172017-02-011573281901475916WOS;000394268800009PUBMED;28239215SCOPUS;2-s2.0-84982311168http://hdl.handle.net/10784/26634The Techniques for Overcoming Depression (TOD) questionnaire assesses the frequency with which patients being treated for depression use cognitive-behavioral techniques in daily life. This study examined its latent structure, reliability and concurrent validity in depressed cardiac patients. The TOD was administered at the initial and final treatment sessions in three trials of cognitive behavior therapy (CBT) (n = 260) for depression in cardiac patients. Mokken scaling was used to determine its dimensionality. The TOD is unidimensional in depressed cardiac patients, both at the initial evaluation (H = .46) and the end of treatment (H = .47). It is sensitive to change and the total score correlates with therapist ratings of the patient’s socialization to CBT (r = .40, p < .05), homework adherence (r = .36, p < .05), and use of cognitive-behavioral techniques (r = .51, p < .01). TOD scores were associated with post-treatment depression scores in two of the trials (p < .01 in both analyses). The TOD is a unidimensional, reliable, valid, and clinically informative measure of self-reported use of cognitive-behavioral techniques for overcoming depression in cardiac patients. Studies of the TOD in other depressed patient populations are needed. © 2016, Springer Science+Business Media New York.enghttps://v2.sherpa.ac.uk/id/publication/issn/1573-2819The Techniques for Overcoming Depression Questionnaire: Mokken Scale Analysis, Reliability, and Concurrent Validity in Depressed Cardiac Patientsinfo:eu-repo/semantics/articleantidepressant agentadultArticlecardiac patientcognitive behavioral therapyconcurrent validitycoronary artery bypass graftCronbach alpha coefficientdepression assessmentfemaleheart failurehumanischemic heart diseasemajor clinical studymajor depressionmalemiddle agedMokken scalepatient compliancerating scaleself reportsocializationTechniques for Overcoming Depression questionnairetreatment resistant depression2021-03-17Freedland, K.E.Lemos, M.Doyle, F.Steinmeyer, B.C.Csik, I.Carney, R.M.10.1007/s10608-016-9797-6